Dx dialogues: how AI can be integrated in the management of AD
Anton Porsteinsson, MD, explains how AI might be used to create dynamic surveys for patients living with AAD.
Up Next
Dx dialogues: novel approaches in development for the treatment of AD
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Dx dialogues: overlapping symptomatology of Alzheimer's and other neurodegenerative disorders
Dx dialogues: disease-modifying therapies for Alzheimer's and the hope for a cure
Dx dialogues: blood-based biomarkers and other diagnostic tools for Alzheimer's and related dementias
Dx dialogues: why early intervention is critical in managing tardive dyskinesia
Dx dialogues: artificial intelligence in OUD treatment and outcomes prediction
Dx dialogues: how precision medicine is changing the AD landscape
Dx dialogues: the challenges of treating tardive dyskinesia the "old-fashioned way"
Dx dialogues: identifying patients who might benefit from an LAI for schizophrenia
